| Description |
1 online resource : illustrations |
| Series |
Virology research progress |
|
Virology research progress series.
|
| Contents |
HEPATITIS B: NEW RESEARCH; HEPATITIS B: NEW RESEARCH; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter I: Chemo -- and Immunotherapeutic Approaches for the Treatment of Hepatitis B Virus Infection; Abstract; Introduction; The Hepatitis B Virus; Life Cycle of Hepatitis B Virus; Therapeutic Approaches in Chronic Hepatitis B (CHB) Virus Infection; Current Chemotherapeutic Agents; Lamivudine (3-TC); Hepsera (Adefovir Dipivoxil, ADV); Tenofovir Disoproxil Fumarate (TDF); Telbivudine; Entecavir (Baraclude); Oxymatrine; Chemotherapeutic Agents in Pipeline; Clevudine |
|
ElvucitabineEmtricitabine; FLG; Amdoxovir; LB80380; Pradefovir; Other Nucleosides under Investigation; Acyclic Pyrimidine Nucleosides; Non-Nucleoside Agents in Pipeline; Bay 41-4109; n- (n-Nonyl)- Deoxygalactonojirimycin; MCC -- 478; Phenylpropenamide Derivatives AT- 61 and AT- 130; Current Immunotherapeutic Agents; Interferon-Ü (IFN-a); Pegylated interferon (PEG-IFN); Immunoglobulins ; Immunotherapeutic Agents in Pipeline; Immunomodulators; REP 9AC; Zadaxin (Thymosin-a); GS-9620; Therapeutic Vaccines; DV-601; Miscellaneous; NOV-205 (BAM-205); Myrcludex B; CYT107 or Interleukin 7 (IL-7) |
|
Dendritic Cells (DC) Based TherapyCombination Therapy; 1. Combination of Chemotherapeutic Agents; Lamivudine Plus Adefovir Dipivoxil; Lamivudine Plus Telbivudine; Adefovir Dipivoxil Plus Emtricitabine; Tenofovir Disoproxil Plus Emtricitabine; Tenofovir Disoproxil Plus Entecavir; Adefovir Plus Entecavir; 2. Combination of Chemotherapeutic and Immunotherapeutic Agent(s); Lamivudine Plus Interferon; Lamivudine Plus Peginterferon; Hepatitis B e Antigen-Positive Chronic Hepatitis; Hepatitis B e Antigen-Negative Chronic Hepatitis; Telbivudine Plus Peginterferon; Adefovir Plus Peginterferon |
|
Interleukin-12 (IL-12) Plus LamivudineConventional IFN Plus Ribavirin; PEG- IFN Plus Ribavirin; Thymosin Plus Lamivudine (Plus IFN); 3. Combination Therapy Using Two Immunomodulators; Thymosin-Ü1 Plus IFN; Vaccine Plus IFNs; Conclusion; References; Chapter II: Hepatitis B and Dialysis; Abstract; Introduction; Epidemiology; HBV Transmission within Dialysis Units; Hepatitis B Serologic Markers; Hepatitis B Surface Antigen and Antibody; Hepatitis B Core Antigen and Antibody; Isolated Anti-HBc ; Hepatitis B E Antigen and Antibody; Hepatitis B Vaccination; The Hepatitis B Vaccine |
|
Efficacy of Hepatitis B VaccineStrategies for Improving Immune Response; Treatment of Hepatitis B in Dialysis Patients; Interferon-Alfa; Nucleoside or Nucleotide Analogues; Conclusion; References; Chapter III: Novel Carrier(s) Based Vaccine Design against Hepatitis B: Recent Updates; Abstract; 1. Introduction; 2. Hepatitis B Virus and Vaccination: An Insight; 3. Mucosal Immunization Against Hepatitis B; 3.1. Oral Immunization; 3.2. Nasal Immunization; 3.3. Topical Immunization; 4. Novel Carrier Based Hepatitis B Vaccine; 4.1. Liposomes; 4.2. PLGA Micro/Nano-particles |
| Bibliography |
Includes bibliographical references and index |
| Notes |
English |
|
Print version record |
| Subject |
Hepatitis B -- Research
|
|
MEDICAL -- Hepatology.
|
|
Hepatitis B
|
| Form |
Electronic book
|
| LC no. |
2020677601 |
| ISBN |
9781620818541 |
|
162081854X |
|
